摘要:Dear Editor in Chief: Multidrug-resistant TB (MDR-TB) is a major chal-lenge to TB control program. MDR-TB pa-tient is resistant to treatment with at least two of the common. Strong first-line treatment anti-TB drugs contain isoniazid and rifampicin.